March 10 (Reuters) - Freeline Therapeutics Holdings PLC
FRLN.O :
* FREELINE ANNOUNCES $26.1 MILLION REGISTERED DIRECT
OFFERING OF
AMERICAN DEPOSITARY SHARES
* FREELINE THERAPEUTICS - PURCHASE AN AGGREGATE OF $26.1
MILLION
OF ITS ADS, EACH REPRESENTING ONE ORDINARY SHARE OF COMPANY AT A
PRICE OF $1.05 PER ADS
* FREELINE THERAPEUTICS HOLDINGS - TO USE PROCEEDS TO FUND
ACTIVITIES RELATING TO CONTINUED DEVELOPMENT OF PRODUCT
CANDIDATES AND GENE THERAPY PLATFORM
Source text for Eikon: ID:nGNX4g8kcG
Further company coverage: FRLN.O
((Reuters.Briefs@thomsonreuters.com;))